Dietary phosphate absorption (null)

Dietary phosphate absorption is the process by which inorganic phosphate from consumed food is absorbed through the small intestine. This process has two main molecular mechanisms: a saturable, transcellular pathway mediated by sodium-dependent phosphate transporters (notably NaPi-IIb/SLC34A2, PiT1/SLC20A1, PiT2/SLC20A2) and a nonsaturable, paracellular pathway, the latter accounting for 65-80% of uptake in humans. Active transcellular transport predominates when dietary phosphate is low; the paracellular route is dominant under normal or high phosphate availability. The process is finely regulated by endocrine factors such as PTH, FGF23, and vitamin D, which modulate transporter expression and function. Aberrations in this absorption process contribute to pathology in conditions such as chronic kidney disease and may be the therapeutic focus of phosphate binders and experimental transporter inhibitors. Key clarification: "Dietary phosphate absorption" is not an individual molecular target or receptor. The critical targets for therapeutic intervention are the transporters (e.g., NaPi-IIb, PiT1, PiT2) and tight junction proteins regulating this process. For structured drug discovery or disease modeling, specifying such molecular entities is necessary.

Other names

Intestinal phosphate absorptionGastrointestinal phosphate uptakePi absorptionPhosphate uptake

Phosphate binders: Bind dietary phosphate in the gut, preventing absorption. NaPi-IIb inhibitors: Block active, transcellular intestinal phosphate uptake (experimental).